Merck & Co. Inc. Stock Advances 12.6%, Outperforms Peers
Dow Jones2026/08/19 20:33This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Merck & Co. Inc. jumped 12.6% to $152.20 on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.2% to 7,707.98 and the Dow Jones Industrial Average rising 0.2% to 53,463.05.
Merck & Co. Inc. hit a new 52-week high, surpassing its previous peak of $137.98, which the company reached on August 18th.
The stock outperformed some of its peers, as Johnson & Johnson rose 0.8% to $273.41, Pfizer Inc. rose 3.6% to $28.24, and Eli Lilly & Co. rose 4.46% to $1,280.34.
Trading volume totaled 32.4 million, compared to the 50-day average of 10.1 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
August 19, 2026 16:33 ET (20:33 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Is the Federal Reserve repeating the 2022-style rate hikes? Bank of America warns: Rates may return above 5%, suggests shorting two-year U.S. Treasuries.
Bank of America warns: With Waller at the helm, the Federal Reserve may raise interest rates above 5%, potentially repeating the events of 2022.
OpenAI is expected to burn over $278 billion in cash by 2030, with a revenue target of $350 billion over the same period.
OpenAI is expected to generate up to $278 billion in negative free cash flow over the next five years, driven solely by computing power and infrastructure, with cumulative spending projected to reach approximately $856 billion by 2030. The company anticipates revenue of $350 billion in 2030 and $36 billion in 2026, with total revenue from 2026 to 2030 amounting to around $840 billion.
Garrett Jin's ZEC short position has an unrealized loss of $33.422 million.
Crypto prices
More
